Partner Headlines - AMGN

  1. Stocks End With Small Gains; Amgen Shrugs Off Drug Data

    IBD
  2. AMGEN

    IBD
  3. Top 4 Stocks In The Biotechnology Industry With The Highest Revenue

    Benzinga
  4. 4 Top-Rated Drugmakers Beat Q2 Earnings Estimates

    IBD
  5. Cancer 'Cocktail' Passes Test

    IBD
  6. Nasdaq Leads In Quiet Session; Priceline Nears Buy Point

    IBD
  7. Amgen Cancer Drug Kyprolis Succeeds In Trial

    IBD
  8. Morning Market Movers

    Benzinga
  9. Benzinga's Top #PreMarket Gainers

    Benzinga
  10. UPDATE: Amgen Announces Phase 3 ASPIRE Trial of Kyprolis Met ...

    Benzinga
  11. Stocks Mixed Despite Better-Than-Expected GDP

    Benzinga
  12. Amgen Price Target Raised by Various Analysts

    Benzinga
  13. Amgen Restructuring Plan, Q2 Earnings Send Stock Up

    IBD
  14. Quarterly “Beats”: Bah, Here Are Real Growers

    YCharts
  15. Amgen To Slash Workforce

    IBD
  16. Indexes End Lower As Russia Sanctions Hit Stocks

    IBD
  17. Stock Futures Show Some Muscle; Merck, Cognex Rising

    IBD
  18. Earnings Scheduled For July 29, 2014

    Benzinga
  19. Top 5 Earnings Reports To Watch After The Close Tue.

    IBD
  20. Pfizer, Merck, Amgen Near Q2 Earnings Reports

    IBD
  21. Benzinga Weekly Preview: FOMC In Focus, As Earnings Season Progresses

    Benzinga
  22. US Stock Futures Drop Ahead Of Durable Goods Orders Data

    Benzinga
  23. Biotech Enters Reporting Season With Large Caps Central To Sector ...

    Benzinga
  24. UPDATE: Amgen Announces Positive Phase 3 Results For AMG 416 ...

    Benzinga
  25. Yellen Swats Down Biotech, Social Media Stocks

    FoxBusiness
  26. Morgan Stanley Issues 2015 'Vintage Values' Stock List

    Benzinga
  27. Celgene Drug Otezla Fails Trial, But Street Sanguine

    IBD
  28. Alexion Pharma Looks To Life Beyond Its Blockbuster

    IBD
  29. Bind Therapeutics

    IBD
  30. Citi Sees Plenty Of Q2 Earnings Beats Ahead In Biotech Sector

    Benzinga
  31. Bind Therapeutics Down After Losing Amgen Partnership

    IBD
  32. Dow Hits 17,000 On Jobs Report; Walgreen Same-Store-Sales Surge ...

    Benzinga
  33. Morning Market Losers

    Benzinga
  34. Top 4 Stocks In The Biotechnology Industry With The Highest EPS

    Benzinga
  35. Benzinga's M&A Chatter for Monday June 16, 2014

    Benzinga
  36. InterMune Up On Bullish View Of U.S. Esbriet Launch

    IBD
  37. UPDATE: Morgan Stanley Reiterates On Amgen On New CFO

    Benzinga
  38. Teva Acquiring Labrys Biologics For Migraine Drug

    IBD
  39. UPDATE: Morgan Stanley Reiterates On Amgen Following AMAGINE-1 ...

    Benzinga
  40. Gulf Resources (GURE) Impressive Performance, Amgen (AMGN) and ...

    GuruFocus
  41. Amgen

    IBD
  42. Top 4 NASDAQ Stocks In The Biotechnology Industry With The Highest ...

    Benzinga
  43. Amgen Blazed Biotech Trail, Earned 165,233% Reward

    IBD
  44. Market Wrap For April 23: S&P 500 Ends Winning Streak, Apple ...

    Benzinga
  45. Stocks End Six-Day Win Streak As Techs Sell Off

    IBD
  46. Stock Futures Mixed And Busy; Illumina Rockets, Cree Tumbles

    IBD
  47. #PreMarket Primer: Wednesday, April 23: Data From China Takes ...

    Benzinga
  48. AMGEN

    IBD
  49. Gilead Soars As Hep C Drug Shatters Views; Amgen Misses

    IBD
  50. Rallying Ahead of Earnings

    FoxBusiness
  51. Nasdaq, S&P 500 On Track For Sixth Straight Gain

    IBD
  52. Amgen Slumps After 1Q Earnings Miss

    FoxBusiness
  53. Stocks Power Out Early Gains; Allergan Leads Drug-Maker Surge

    IBD
  54. Earnings Scheduled For April 22, 2014

    Benzinga
  55. Biohazard? Gilead Leads 5 Big-Cap Biotech Earnings

    IBD
  56. Short Interest Rises As Biotechs Fall (AMGN, CELG, DNDN)

    Benzinga
  57. Pfizer Breast-Cancer Drug Scores, But Street Cautious

    IBD
  58. UPDATE: Amgen Spiking Lower 1.5%, Says Primary Endpoint of Durable ...

    Benzinga
  59. Amgen, GSK End Marketing Pact for Osteoporosis Drug

    FoxBusiness
  60. Cholesterol drug meets goal

    IBD
  61. Trial Results Lift Drug Sector

    IBD
  62. Amgen Stock Gets Bump Up On Cholesterol Drug Data

    IBD
  63. Jefferies Raises PT On Amgen, Pricing Pressure Factored IN

    Benzinga
  64. Gilead Adds To Biotech Woes

    IBD
  65. Gilead Sovaldi Scrips Falter As Biotechs Keep Falling

    IBD
  66. New Cholesterol Fighters To Take Center Stage At ACC

    IBD
  67. Market Wrap For March 27: Markets Lower Following Mixed Economic ...

    Benzinga
  68. Biotech ETFs Come Back Down To Earth

    Benzinga
  69. Morgan Stanley's Top Biotech Pick is Biogen

    Benzinga
  70. BIOGEN IDEC

    IBD
  71. Have We Seen The Top Of The Market?

    Benzinga
  72. Market Wrap For March 18: Markets Positive Despite Crimea Concerns

    Benzinga
  73. Amgen up on drug trial result

    IBD
  74. Amgen's PCSK9 Scores Against Genetic High Cholesterol

    IBD
  75. US Stock Futures Edge Lower Ahead Of Wholesale Trade Data

    Benzinga
  76. Bayer, Onyx Report Primary Endpoint of Phase 3 Study Results ...

    Benzinga
  77. Regeneron Cholesterol-Drug Worries Ding Stock

    IBD
  78. Biogen Idec Keeps Momentum Going With MS Drug Tecfidera

    IBD
  79. Insys Set To Report Q4 Earnings With Stock Surging

    IBD
  80. Why Stock Shakeouts Can Be Scary, Yet Constructive

    IBD
  81. Amgen, BioMarin Lead Biotech Short Interest Trend (AMGN, BIIB, ...

    Benzinga
  82. Novartis Vs. Everyone: Biologic Knockoffs

    YCharts
  83. Revenue Growth: Focus On Healthcare Stocks

    YCharts
  84. France's Biosimilar Substitution May Lead to Erosion of Amgen

    Benzinga
  85. Why Mr. Cautious Is 82% Invested In Stocks

    YCharts
  86. Illumina, Alexion Lead 4 Big Caps Drawing Big Buyers

    IBD
  87. You Can No Longer Ignore Biotech

    GuruFocus
  88. Merck soars on cancer deal

    IBD
  89. Merck Q4 Misses, But Cancer Deals Ignite Stock

    IBD
  90. Merck Misses Estimates in 4Q; Plans Increased Focus on Cancer

    FoxBusiness
  91. Amgen Announces Positive Top-Line Results From Phase 3 RUTHERFORD-2 ...

    Benzinga
  92. Pfizer, Amgen Earnings Beat

    IBD
  93. Amgen Announces Positive Top-Line Results From Phase 3 LAPLACE-2 ...

    Benzinga
  94. Earnings Scheduled For January 28, 2014

    Benzinga
  95. Benzinga Weekly Preview: Tech Sector To Steal The Spotlight

    Benzinga
  96. Amgen

    IBD
  97. Amgen Announces Positive Top-Line Results From Phase 3 GAUSS-2 ...

    Benzinga
  98. Drugmaker Merck Tries To Jump-Start Slow Growth

    IBD
  99. Illumina, Jazz Among 5 Young Guns Hitting New Highs

    IBD
  100. Illumina Details Its Strategy; Stock Jumps Again

    IBD
Trading Center